Quotient Sciences: Adaptable CMC strategies for your expedited drug program
16 Sep 2025
Sponsored by Quotient Sciences
If you’re pursuing an accelerated development pathway, choose a CDMO partner that embraces shared success for your product launch and has the experience to overcome CMC challenges along the way – Quotient Sciences.
With small-scale commercial batch manufacturing capabilities and a range of drug product formulation and manufacturing services, learn how Quotient Sciences helps navigate expedited review pathways in our recent whitepaper.
Most Viewed
Winston House, 3rd Floor, Units 306-309, 2-4 Dollis Park, London, N3 1HF
23-29 Hendon Lane, London, N3 1RT
020 8349 4363
© 2025, Lyonsdown Limited. Business Reporter® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543